Sangamo Therapeutics (SGMO) Assets (2016 - 2025)
Historic Assets for Sangamo Therapeutics (SGMO) over the last 17 years, with Q3 2025 value amounting to $88.6 million.
- Sangamo Therapeutics' Assets fell 2033.02% to $88.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $88.6 million, marking a year-over-year decrease of 2033.02%. This contributed to the annual value of $101.6 million for FY2024, which is 3852.23% down from last year.
- Latest data reveals that Sangamo Therapeutics reported Assets of $88.6 million as of Q3 2025, which was down 2033.02% from $97.6 million recorded in Q2 2025.
- In the past 5 years, Sangamo Therapeutics' Assets ranged from a high of $877.1 million in Q1 2021 and a low of $86.2 million during Q1 2025
- Over the past 5 years, Sangamo Therapeutics' median Assets value was $325.1 million (recorded in 2023), while the average stood at $394.3 million.
- Per our database at Business Quant, Sangamo Therapeutics' Assets surged by 5011.66% in 2021 and then plummeted by 7138.68% in 2024.
- Sangamo Therapeutics' Assets (Quarter) stood at $721.9 million in 2021, then dropped by 22.08% to $562.5 million in 2022, then tumbled by 70.61% to $165.3 million in 2023, then crashed by 38.52% to $101.6 million in 2024, then dropped by 12.78% to $88.6 million in 2025.
- Its Assets was $88.6 million in Q3 2025, compared to $97.6 million in Q2 2025 and $86.2 million in Q1 2025.